{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:50:11Z","timestamp":1779281411927,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1989,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/modpathol.2017.37","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T07:41:24Z","timestamp":1495784484000},"page":"1100-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["EBV-negative aggressive NK-cell leukemia\/lymphoma: a clinical and pathological study from a single institution"],"prefix":"10.1016","volume":"30","author":[{"given":"Juehua","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Behdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristy L","family":"Wolniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Frankfurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.37_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"276","author":"Chan","year":"2008"},{"key":"10.1038\/modpathol.2017.37_bib2","first-page":"ED07","article-title":"Natural killer cell lymphoma: a case with classification dilemma","volume":"10","author":"Jitani","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1038\/modpathol.2017.37_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000040955","article-title":"Monomorphic agranular natural killer cell lymphoma\/leukemia with no Epstein-Barr virus association","volume":"101","author":"Matano","year":"1999","journal-title":"Acta Haematol"},{"key":"10.1038\/modpathol.2017.37_bib4","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4081\/hr.2012.e16","article-title":"Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2","volume":"4","author":"Perkovic","year":"2012","journal-title":"Hematol Rep"},{"key":"10.1038\/modpathol.2017.37_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12185-013-1319-7","article-title":"Favorable outcome in a child with EBV-negative aggressive NK cell leukemia","volume":"97","author":"Park","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1038\/modpathol.2017.37_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2017.37_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000193225","article-title":"Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?","volume":"120","author":"Ko","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1038\/modpathol.2017.37_bib8","first-page":"3423","article-title":"Six cases of aggressive natural killer-cell leukemia in a Chinese population","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/modpathol.2017.37_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features","volume":"41","author":"Nicolae","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.37_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s13277-015-3977-y","article-title":"The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications","volume":"37","author":"Kim","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1038\/modpathol.2017.37_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","article-title":"Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling","volume":"223","author":"Ng","year":"2011","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2017.37_bib12","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2012-08-450494","article-title":"EZH2 overexpression in natural killer\/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity","volume":"121","author":"Yan","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.37_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2017.37_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1476-4598-9-151","article-title":"Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK\/T-cell lines","volume":"9","author":"Nagel","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1038\/modpathol.2017.37_bib15","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3109\/10428194.2015.1006220","article-title":"Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation","volume":"56","author":"Zhou","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2017.37_bib16","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1080\/10428190400004513","article-title":"Aggressive natural killer-cell leukemia: report of five cases and review of the literature","volume":"45","author":"Ruskova","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2017.37_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PAT.0000000000000275","article-title":"Extranodal NK\/T cell lymphoma and aggressive NK cell leukaemia: evidence for their origin on CD56+bright CD16-\/+dim NK cells","volume":"47","author":"Lima","year":"2015","journal-title":"Pathology"},{"key":"10.1038\/modpathol.2017.37_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/10428194.2014.905772","article-title":"Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells","volume":"56","author":"Lima","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2017.37_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212103","article-title":"The first report of a previously undescribed EBV-negative NK-cell lymphoma of the GI tract presenting as chronic diarrhoea with eosinophilia","author":"Zaheen","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1038\/modpathol.2017.37_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1532\/IJH97.A10612","article-title":"Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature","volume":"85","author":"Ryder","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1038\/modpathol.2017.37_bib21","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.3748\/wjg.v20.i14.3916","article-title":"DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus","volume":"20","author":"Matsusaka","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1038\/modpathol.2017.37_bib22","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-11-3919","article-title":"Epstein-Barr virus infection as an epigenetic driver of tumorigenesis","volume":"72","author":"Kaneda","year":"2012","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.37_bib23","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.37_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-12-2522","article-title":"MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase","volume":"73","author":"Kaur","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.37_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.18632\/oncotarget.327","article-title":"Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms","volume":"2","author":"Koh","year":"2011","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2017.37_bib26","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 is essential for glioblastoma cancer stem cell maintenance","volume":"69","author":"Suva","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.37_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00018-013-1426-x","article-title":"Polycomb group proteins and MYC: the cancer connection","volume":"71","author":"Benetatos","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/modpathol.2017.37_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/MCB.06148-11","article-title":"Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells","volume":"32","author":"Neri","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1038\/modpathol.2017.37_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1038\/modpathol.2017.37_bib30","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.37_bib31","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2017.37_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5808\/GI.2016.14.3.78","article-title":"Mutational analysis of extranodal NK\/T-cell lymphoma using targeted sequencing with a comprehensive cancer panel","volume":"14","author":"Choi","year":"2016","journal-title":"Genomics Inform"},{"key":"10.1038\/modpathol.2017.37_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","article-title":"JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma","volume":"28","author":"Bouchekioua","year":"2014","journal-title":"Leukemia"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201737","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:40:06Z","timestamp":1760229606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0893395222007463"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.37","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EBV-negative aggressive NK-cell leukemia\/lymphoma: a clinical and pathological study from a single institution","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.37","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.85","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}